Recommandations pour une approche de santé publique
Policy Guidelines for Health Facilities
Journal of the International AIDS Society Vol. 21 (2018) e25133
Many prevention of mother-to-child HIV transmission programmes across Africa initiate HIV-infected (HIV positive) pregnant women on lifelong antiretroviral therapy (ART) on the first day of antenatal care (“same-day” initiation...). However, there are concerns that same-day initiation may limit patient preparation before starting ART and contribute to subsequent non-adherence, disengagement from care and raised viral load. We examined if same-day initiation was associated with viral suppression and engagement in care during pregnancy.
The data suggest that same-day ART initiation during pregnancy is not associated with lower levels of engagement in care or viral suppression through 12 months post-delivery in this setting, providing reassurance to ART programmes implementing Option B+.
https://doi.org/10.1002/jia2.25133
more
O presente Guião de Bolso referente ao Tratamento antiretroviral e de infecções oportunistas
do adulto, adolescente e criança é um instrumento de grande utilidade para os profissionais de saúde, em especial os envolvidos no tratamento dos pacientes infectados pelo HIV em Moçambique. O Guião... salvaguarda uma abordagem correcta, atempada e padronizada no atendimento aos pacientes com HIV/SIDA, garantindo o uso racional e cientificamente fundamentado dos escassos recursos existentes.
more
Supplement Article
J Acquir Immune Defic Syndr Volume 75, Supplement 2, June 1, 2017 www.jaids.com
Review
www.co-hivandaids.com
Volume 12 Number 4 July 2017
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...ing access to affordable antiretroviral therapy (ART).
The report is supplemented by 11 drug profiles that contain more detailed information on pricing trends and patent barriers for key antiretroviral drugs and fixed-dose combinations. Also included is an annex of conditions that define eligibility for reduced prices from 15 pharmaceutical companies.
more
AIDS Research and Therapy 2015, 12:12 (24 April 2015)
HIV Treatment
Policy Brief
July 2017
Recommendations, resources and references
A publication of the Southern African HIV Clinicians Society
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...tions are available that provide a background to pharmacovigilance and, as far as possible, that material will not be repeated here. Health officials, planners, the staff of Pharmacovigilance Centres, public health teams and all health workers should become familiar with these publications, which are: • Safety of Medicines: A guide to detecting and reporting adverse drug reactions
more
Technical Update
HIV Treatment
July 2017
PLOS ONE | https://doi.org/10.1371/journal.pone.0196239 April 23, 2018
Yu et al. BMC Public Health (2018) 18:825 https://doi.org/10.1186/s12889-018-5731-z
Research Article